1. Home
  2. MRM vs CURX Comparison

MRM vs CURX Comparison

Compare MRM & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MRM

MEDIROM Healthcare Technologies Inc.

N/A

Current Price

$1.18

Market Cap

10.0M

ML Signal

N/A

CURX

Curanex Pharmaceuticals Inc

N/A

Current Price

$0.52

Market Cap

11.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRM
CURX
Founded
2000
2018
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
11.6M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
MRM
CURX
Price
$1.18
$0.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
174.4K
5.6M
Earning Date
05-22-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.26
52 Week High
$4.45
$9.18

Technical Indicators

Market Signals
Indicator
MRM
CURX
Relative Strength Index (RSI) 26.45 67.50
Support Level $1.10 $0.37
Resistance Level $1.64 $0.67
Average True Range (ATR) 0.06 0.05
MACD -0.00 0.01
Stochastic Oscillator 9.09 80.66

Price Performance

Historical Comparison
MRM
CURX

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

Share on Social Networks: